nodes	percent_of_prediction	percent_of_DWPC	metapath
Trospium—CYP2D6—Bicalutamide—prostate cancer	0.099	0.504	CbGbCtD
Trospium—CYP2D6—Abiraterone—prostate cancer	0.082	0.418	CbGbCtD
Trospium—CHRM3—ureter—prostate cancer	0.0388	0.542	CbGeAlD
Trospium—CYP2D6—Doxorubicin—prostate cancer	0.0152	0.0773	CbGbCtD
Trospium—CYP2D6—urine—prostate cancer	0.00682	0.0952	CbGeAlD
Trospium—CHRM2—prostate gland—prostate cancer	0.00556	0.0776	CbGeAlD
Trospium—CHRM1—prostate gland—prostate cancer	0.00506	0.0706	CbGeAlD
Trospium—CHRM3—prostate gland—prostate cancer	0.00453	0.0632	CbGeAlD
Trospium—CHRM3—renal system—prostate cancer	0.00309	0.0431	CbGeAlD
Trospium—CHRM3—urethra—prostate cancer	0.00303	0.0423	CbGeAlD
Trospium—CHRM3—testis—prostate cancer	0.00199	0.0278	CbGeAlD
Trospium—CYP2D6—renal system—prostate cancer	0.00167	0.0233	CbGeAlD
Trospium—CYP2D6—testis—prostate cancer	0.00108	0.0151	CbGeAlD
Trospium—Methadone—CYP2C18—prostate cancer	0.00061	0.19	CrCbGaD
Trospium—Benzatropine—CYP2C19—prostate cancer	0.000551	0.172	CrCbGaD
Trospium—Ipratropium bromide—CYP3A4—prostate cancer	0.000428	0.134	CrCbGaD
Trospium—Methadone—CYP3A5—prostate cancer	0.000402	0.125	CrCbGaD
Trospium—Darifenacin—CYP3A4—prostate cancer	0.000395	0.123	CrCbGaD
Trospium—Methadone—CYP19A1—prostate cancer	0.00037	0.116	CrCbGaD
Trospium—Methadone—CYP2C19—prostate cancer	0.000274	0.0854	CrCbGaD
Trospium—Vision blurred—Capecitabine—prostate cancer	0.000225	0.000385	CcSEcCtD
Trospium—Asthenia—Estradiol—prostate cancer	0.000225	0.000383	CcSEcCtD
Trospium—Dysuria—Epirubicin—prostate cancer	0.000224	0.000382	CcSEcCtD
Trospium—Abdominal distension—Doxorubicin—prostate cancer	0.000223	0.00038	CcSEcCtD
Trospium—Angiopathy—Prednisone—prostate cancer	0.000222	0.000379	CcSEcCtD
Trospium—Syncope—Docetaxel—prostate cancer	0.000221	0.000378	CcSEcCtD
Trospium—Pruritus—Estradiol—prostate cancer	0.000221	0.000378	CcSEcCtD
Trospium—Influenza—Doxorubicin—prostate cancer	0.000221	0.000378	CcSEcCtD
Trospium—Pollakiuria—Epirubicin—prostate cancer	0.000221	0.000377	CcSEcCtD
Trospium—Palpitations—Docetaxel—prostate cancer	0.000218	0.000373	CcSEcCtD
Trospium—Photosensitivity reaction—Epirubicin—prostate cancer	0.000218	0.000372	CcSEcCtD
Trospium—Weight increased—Epirubicin—prostate cancer	0.000218	0.000371	CcSEcCtD
Trospium—Loss of consciousness—Docetaxel—prostate cancer	0.000217	0.00037	CcSEcCtD
Trospium—Somnolence—Etoposide—prostate cancer	0.000216	0.000368	CcSEcCtD
Trospium—Angina pectoris—Doxorubicin—prostate cancer	0.000215	0.000368	CcSEcCtD
Trospium—Syncope—Capecitabine—prostate cancer	0.000214	0.000366	CcSEcCtD
Trospium—Infestation NOS—Epirubicin—prostate cancer	0.000213	0.000364	CcSEcCtD
Trospium—Infestation—Epirubicin—prostate cancer	0.000213	0.000364	CcSEcCtD
Trospium—Malnutrition—Prednisone—prostate cancer	0.000213	0.000364	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000211	0.000361	CcSEcCtD
Trospium—Palpitations—Capecitabine—prostate cancer	0.000211	0.000361	CcSEcCtD
Trospium—Decreased appetite—Etoposide—prostate cancer	0.000211	0.00036	CcSEcCtD
Trospium—Chest pain—Docetaxel—prostate cancer	0.00021	0.000359	CcSEcCtD
Trospium—Loss of consciousness—Capecitabine—prostate cancer	0.00021	0.000359	CcSEcCtD
Trospium—Gastrointestinal disorder—Etoposide—prostate cancer	0.000209	0.000357	CcSEcCtD
Trospium—Asthenia—Mitoxantrone—prostate cancer	0.000209	0.000357	CcSEcCtD
Trospium—Fatigue—Etoposide—prostate cancer	0.000209	0.000357	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000209	0.000356	CcSEcCtD
Trospium—Stomatitis—Epirubicin—prostate cancer	0.000208	0.000355	CcSEcCtD
Trospium—Constipation—Etoposide—prostate cancer	0.000207	0.000354	CcSEcCtD
Trospium—Urinary tract infection—Epirubicin—prostate cancer	0.000207	0.000354	CcSEcCtD
Trospium—Dizziness—Estradiol—prostate cancer	0.000207	0.000353	CcSEcCtD
Trospium—Dysuria—Doxorubicin—prostate cancer	0.000207	0.000353	CcSEcCtD
Trospium—Dry mouth—Docetaxel—prostate cancer	0.000206	0.000351	CcSEcCtD
Trospium—Pollakiuria—Doxorubicin—prostate cancer	0.000204	0.000349	CcSEcCtD
Trospium—Chest pain—Capecitabine—prostate cancer	0.000204	0.000347	CcSEcCtD
Trospium—Haematuria—Epirubicin—prostate cancer	0.000203	0.000347	CcSEcCtD
Trospium—Confusional state—Docetaxel—prostate cancer	0.000203	0.000347	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000202	0.000345	CcSEcCtD
Trospium—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000202	0.000345	CcSEcCtD
Trospium—Oedema—Docetaxel—prostate cancer	0.000202	0.000344	CcSEcCtD
Trospium—Anaphylactic shock—Docetaxel—prostate cancer	0.000202	0.000344	CcSEcCtD
Trospium—Weight increased—Doxorubicin—prostate cancer	0.000201	0.000344	CcSEcCtD
Trospium—Vision blurred—Prednisone—prostate cancer	0.000201	0.000343	CcSEcCtD
Trospium—Infection—Docetaxel—prostate cancer	0.0002	0.000342	CcSEcCtD
Trospium—Feeling abnormal—Etoposide—prostate cancer	0.0002	0.000341	CcSEcCtD
Trospium—Dry mouth—Capecitabine—prostate cancer	0.000199	0.00034	CcSEcCtD
Trospium—Vomiting—Estradiol—prostate cancer	0.000199	0.00034	CcSEcCtD
Trospium—Gastrointestinal pain—Etoposide—prostate cancer	0.000198	0.000339	CcSEcCtD
Trospium—Shock—Docetaxel—prostate cancer	0.000198	0.000338	CcSEcCtD
Trospium—Nervous system disorder—Docetaxel—prostate cancer	0.000198	0.000337	CcSEcCtD
Trospium—Rash—Estradiol—prostate cancer	0.000197	0.000337	CcSEcCtD
Trospium—Infestation NOS—Doxorubicin—prostate cancer	0.000197	0.000337	CcSEcCtD
Trospium—Infestation—Doxorubicin—prostate cancer	0.000197	0.000337	CcSEcCtD
Trospium—Dermatitis—Estradiol—prostate cancer	0.000197	0.000336	CcSEcCtD
Trospium—Confusional state—Capecitabine—prostate cancer	0.000197	0.000336	CcSEcCtD
Trospium—Tachycardia—Docetaxel—prostate cancer	0.000197	0.000336	CcSEcCtD
Trospium—Headache—Estradiol—prostate cancer	0.000196	0.000335	CcSEcCtD
Trospium—Skin disorder—Docetaxel—prostate cancer	0.000196	0.000334	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000196	0.000334	CcSEcCtD
Trospium—Oedema—Capecitabine—prostate cancer	0.000195	0.000333	CcSEcCtD
Trospium—Angioedema—Prednisone—prostate cancer	0.000195	0.000332	CcSEcCtD
Trospium—Infection—Capecitabine—prostate cancer	0.000194	0.000331	CcSEcCtD
Trospium—Urticaria—Etoposide—prostate cancer	0.000193	0.000329	CcSEcCtD
Trospium—Stomatitis—Doxorubicin—prostate cancer	0.000192	0.000328	CcSEcCtD
Trospium—Shock—Capecitabine—prostate cancer	0.000192	0.000328	CcSEcCtD
Trospium—Rhinitis—Epirubicin—prostate cancer	0.000192	0.000327	CcSEcCtD
Trospium—Abdominal pain—Etoposide—prostate cancer	0.000192	0.000327	CcSEcCtD
Trospium—Urinary tract infection—Doxorubicin—prostate cancer	0.000192	0.000327	CcSEcCtD
Trospium—Nervous system disorder—Capecitabine—prostate cancer	0.000191	0.000327	CcSEcCtD
Trospium—Syncope—Prednisone—prostate cancer	0.000191	0.000326	CcSEcCtD
Trospium—Tachycardia—Capecitabine—prostate cancer	0.00019	0.000325	CcSEcCtD
Trospium—Skin disorder—Capecitabine—prostate cancer	0.00019	0.000324	CcSEcCtD
Trospium—Urinary tract disorder—Epirubicin—prostate cancer	0.000189	0.000323	CcSEcCtD
Trospium—Hyperhidrosis—Capecitabine—prostate cancer	0.000189	0.000322	CcSEcCtD
Trospium—Oedema peripheral—Epirubicin—prostate cancer	0.000189	0.000322	CcSEcCtD
Trospium—Haematuria—Doxorubicin—prostate cancer	0.000188	0.000321	CcSEcCtD
Trospium—Connective tissue disorder—Epirubicin—prostate cancer	0.000188	0.000321	CcSEcCtD
Trospium—Urethral disorder—Epirubicin—prostate cancer	0.000188	0.00032	CcSEcCtD
Trospium—Loss of consciousness—Prednisone—prostate cancer	0.000187	0.00032	CcSEcCtD
Trospium—Nausea—Estradiol—prostate cancer	0.000186	0.000317	CcSEcCtD
Trospium—Vomiting—Mitoxantrone—prostate cancer	0.000185	0.000316	CcSEcCtD
Trospium—Visual impairment—Epirubicin—prostate cancer	0.000184	0.000315	CcSEcCtD
Trospium—Rash—Mitoxantrone—prostate cancer	0.000184	0.000314	CcSEcCtD
Trospium—Dermatitis—Mitoxantrone—prostate cancer	0.000184	0.000313	CcSEcCtD
Trospium—Headache—Mitoxantrone—prostate cancer	0.000183	0.000312	CcSEcCtD
Trospium—Erythema multiforme—Epirubicin—prostate cancer	0.000181	0.000309	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00018	0.000307	CcSEcCtD
Trospium—Somnolence—Docetaxel—prostate cancer	0.000179	0.000306	CcSEcCtD
Trospium—Eye disorder—Epirubicin—prostate cancer	0.000179	0.000305	CcSEcCtD
Trospium—Cardiac disorder—Epirubicin—prostate cancer	0.000178	0.000303	CcSEcCtD
Trospium—Flushing—Epirubicin—prostate cancer	0.000178	0.000303	CcSEcCtD
Trospium—Rhinitis—Doxorubicin—prostate cancer	0.000178	0.000303	CcSEcCtD
Trospium—Dyspepsia—Docetaxel—prostate cancer	0.000177	0.000303	CcSEcCtD
Trospium—Decreased appetite—Docetaxel—prostate cancer	0.000175	0.000299	CcSEcCtD
Trospium—Urinary tract disorder—Doxorubicin—prostate cancer	0.000175	0.000298	CcSEcCtD
Trospium—Oedema peripheral—Doxorubicin—prostate cancer	0.000174	0.000298	CcSEcCtD
Trospium—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000174	0.000297	CcSEcCtD
Trospium—Asthenia—Etoposide—prostate cancer	0.000174	0.000297	CcSEcCtD
Trospium—Connective tissue disorder—Doxorubicin—prostate cancer	0.000174	0.000297	CcSEcCtD
Trospium—Methadone—CYP3A4—prostate cancer	0.000174	0.0543	CrCbGaD
Trospium—Anaphylactic shock—Prednisone—prostate cancer	0.000174	0.000297	CcSEcCtD
Trospium—Oedema—Prednisone—prostate cancer	0.000174	0.000297	CcSEcCtD
Trospium—Fatigue—Docetaxel—prostate cancer	0.000174	0.000297	CcSEcCtD
Trospium—Angiopathy—Epirubicin—prostate cancer	0.000174	0.000296	CcSEcCtD
Trospium—Urethral disorder—Doxorubicin—prostate cancer	0.000174	0.000296	CcSEcCtD
Trospium—Nausea—Mitoxantrone—prostate cancer	0.000173	0.000296	CcSEcCtD
Trospium—Infection—Prednisone—prostate cancer	0.000173	0.000295	CcSEcCtD
Trospium—Mediastinal disorder—Epirubicin—prostate cancer	0.000172	0.000294	CcSEcCtD
Trospium—Constipation—Docetaxel—prostate cancer	0.000172	0.000294	CcSEcCtD
Trospium—Dyspepsia—Capecitabine—prostate cancer	0.000172	0.000293	CcSEcCtD
Trospium—Pruritus—Etoposide—prostate cancer	0.000172	0.000293	CcSEcCtD
Trospium—Shock—Prednisone—prostate cancer	0.000171	0.000292	CcSEcCtD
Trospium—Visual impairment—Doxorubicin—prostate cancer	0.000171	0.000291	CcSEcCtD
Trospium—Nervous system disorder—Prednisone—prostate cancer	0.00017	0.000291	CcSEcCtD
Trospium—Tachycardia—Prednisone—prostate cancer	0.00017	0.00029	CcSEcCtD
Trospium—Decreased appetite—Capecitabine—prostate cancer	0.00017	0.00029	CcSEcCtD
Trospium—Skin disorder—Prednisone—prostate cancer	0.000169	0.000288	CcSEcCtD
Trospium—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000168	0.000288	CcSEcCtD
Trospium—Fatigue—Capecitabine—prostate cancer	0.000168	0.000287	CcSEcCtD
Trospium—Hyperhidrosis—Prednisone—prostate cancer	0.000168	0.000287	CcSEcCtD
Trospium—Erythema multiforme—Doxorubicin—prostate cancer	0.000167	0.000286	CcSEcCtD
Trospium—Constipation—Capecitabine—prostate cancer	0.000167	0.000285	CcSEcCtD
Trospium—Malnutrition—Epirubicin—prostate cancer	0.000167	0.000284	CcSEcCtD
Trospium—Feeling abnormal—Docetaxel—prostate cancer	0.000166	0.000283	CcSEcCtD
Trospium—Eye disorder—Doxorubicin—prostate cancer	0.000165	0.000282	CcSEcCtD
Trospium—Gastrointestinal pain—Docetaxel—prostate cancer	0.000165	0.000281	CcSEcCtD
Trospium—Cardiac disorder—Doxorubicin—prostate cancer	0.000164	0.00028	CcSEcCtD
Trospium—Flushing—Doxorubicin—prostate cancer	0.000164	0.00028	CcSEcCtD
Trospium—Flatulence—Epirubicin—prostate cancer	0.000164	0.00028	CcSEcCtD
Trospium—Dysgeusia—Epirubicin—prostate cancer	0.000163	0.000278	CcSEcCtD
Trospium—Back pain—Epirubicin—prostate cancer	0.000161	0.000275	CcSEcCtD
Trospium—Feeling abnormal—Capecitabine—prostate cancer	0.000161	0.000274	CcSEcCtD
Trospium—Angiopathy—Doxorubicin—prostate cancer	0.000161	0.000274	CcSEcCtD
Trospium—Dizziness—Etoposide—prostate cancer	0.00016	0.000274	CcSEcCtD
Trospium—Muscle spasms—Epirubicin—prostate cancer	0.00016	0.000273	CcSEcCtD
Trospium—Gastrointestinal pain—Capecitabine—prostate cancer	0.00016	0.000272	CcSEcCtD
Trospium—Mediastinal disorder—Doxorubicin—prostate cancer	0.00016	0.000272	CcSEcCtD
Trospium—Abdominal pain—Docetaxel—prostate cancer	0.000159	0.000272	CcSEcCtD
Trospium—Vision blurred—Epirubicin—prostate cancer	0.000157	0.000268	CcSEcCtD
Trospium—Urticaria—Capecitabine—prostate cancer	0.000155	0.000265	CcSEcCtD
Trospium—Abdominal pain—Capecitabine—prostate cancer	0.000154	0.000263	CcSEcCtD
Trospium—Vomiting—Etoposide—prostate cancer	0.000154	0.000263	CcSEcCtD
Trospium—Malnutrition—Doxorubicin—prostate cancer	0.000154	0.000263	CcSEcCtD
Trospium—Dyspepsia—Prednisone—prostate cancer	0.000153	0.000261	CcSEcCtD
Trospium—Rash—Etoposide—prostate cancer	0.000153	0.000261	CcSEcCtD
Trospium—Dermatitis—Etoposide—prostate cancer	0.000153	0.000261	CcSEcCtD
Trospium—Headache—Etoposide—prostate cancer	0.000152	0.000259	CcSEcCtD
Trospium—Flatulence—Doxorubicin—prostate cancer	0.000152	0.000259	CcSEcCtD
Trospium—Decreased appetite—Prednisone—prostate cancer	0.000151	0.000258	CcSEcCtD
Trospium—Dysgeusia—Doxorubicin—prostate cancer	0.000151	0.000258	CcSEcCtD
Trospium—Fatigue—Prednisone—prostate cancer	0.00015	0.000256	CcSEcCtD
Trospium—Syncope—Epirubicin—prostate cancer	0.000149	0.000255	CcSEcCtD
Trospium—Back pain—Doxorubicin—prostate cancer	0.000149	0.000254	CcSEcCtD
Trospium—Constipation—Prednisone—prostate cancer	0.000149	0.000254	CcSEcCtD
Trospium—Muscle spasms—Doxorubicin—prostate cancer	0.000148	0.000253	CcSEcCtD
Trospium—Palpitations—Epirubicin—prostate cancer	0.000147	0.000251	CcSEcCtD
Trospium—Loss of consciousness—Epirubicin—prostate cancer	0.000146	0.00025	CcSEcCtD
Trospium—Vision blurred—Doxorubicin—prostate cancer	0.000145	0.000248	CcSEcCtD
Trospium—Asthenia—Docetaxel—prostate cancer	0.000145	0.000247	CcSEcCtD
Trospium—Nausea—Etoposide—prostate cancer	0.000144	0.000246	CcSEcCtD
Trospium—Feeling abnormal—Prednisone—prostate cancer	0.000143	0.000244	CcSEcCtD
Trospium—Pruritus—Docetaxel—prostate cancer	0.000143	0.000243	CcSEcCtD
Trospium—Gastrointestinal pain—Prednisone—prostate cancer	0.000142	0.000243	CcSEcCtD
Trospium—Chest pain—Epirubicin—prostate cancer	0.000142	0.000242	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000141	0.00024	CcSEcCtD
Trospium—Asthenia—Capecitabine—prostate cancer	0.00014	0.000239	CcSEcCtD
Trospium—Dry mouth—Epirubicin—prostate cancer	0.000139	0.000237	CcSEcCtD
Trospium—Syncope—Doxorubicin—prostate cancer	0.000138	0.000236	CcSEcCtD
Trospium—Urticaria—Prednisone—prostate cancer	0.000138	0.000236	CcSEcCtD
Trospium—Pruritus—Capecitabine—prostate cancer	0.000138	0.000236	CcSEcCtD
Trospium—Abdominal pain—Prednisone—prostate cancer	0.000137	0.000235	CcSEcCtD
Trospium—Confusional state—Epirubicin—prostate cancer	0.000137	0.000234	CcSEcCtD
Trospium—Palpitations—Doxorubicin—prostate cancer	0.000136	0.000232	CcSEcCtD
Trospium—Oedema—Epirubicin—prostate cancer	0.000136	0.000232	CcSEcCtD
Trospium—Anaphylactic shock—Epirubicin—prostate cancer	0.000136	0.000232	CcSEcCtD
Trospium—Loss of consciousness—Doxorubicin—prostate cancer	0.000135	0.000231	CcSEcCtD
Trospium—Infection—Epirubicin—prostate cancer	0.000135	0.000231	CcSEcCtD
Trospium—Shock—Epirubicin—prostate cancer	0.000134	0.000228	CcSEcCtD
Trospium—Nervous system disorder—Epirubicin—prostate cancer	0.000133	0.000228	CcSEcCtD
Trospium—Dizziness—Docetaxel—prostate cancer	0.000133	0.000227	CcSEcCtD
Trospium—Tachycardia—Epirubicin—prostate cancer	0.000133	0.000226	CcSEcCtD
Trospium—Skin disorder—Epirubicin—prostate cancer	0.000132	0.000225	CcSEcCtD
Trospium—Hyperhidrosis—Epirubicin—prostate cancer	0.000131	0.000224	CcSEcCtD
Trospium—Chest pain—Doxorubicin—prostate cancer	0.000131	0.000224	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.00013	0.000222	CcSEcCtD
Trospium—Dizziness—Capecitabine—prostate cancer	0.000129	0.00022	CcSEcCtD
Trospium—Dry mouth—Doxorubicin—prostate cancer	0.000128	0.000219	CcSEcCtD
Trospium—Vomiting—Docetaxel—prostate cancer	0.000128	0.000219	CcSEcCtD
Trospium—Rash—Docetaxel—prostate cancer	0.000127	0.000217	CcSEcCtD
Trospium—Dermatitis—Docetaxel—prostate cancer	0.000127	0.000217	CcSEcCtD
Trospium—Confusional state—Doxorubicin—prostate cancer	0.000127	0.000216	CcSEcCtD
Trospium—Headache—Docetaxel—prostate cancer	0.000126	0.000216	CcSEcCtD
Trospium—Oedema—Doxorubicin—prostate cancer	0.000126	0.000215	CcSEcCtD
Trospium—Anaphylactic shock—Doxorubicin—prostate cancer	0.000126	0.000215	CcSEcCtD
Trospium—Infection—Doxorubicin—prostate cancer	0.000125	0.000213	CcSEcCtD
Trospium—Asthenia—Prednisone—prostate cancer	0.000125	0.000213	CcSEcCtD
Trospium—Vomiting—Capecitabine—prostate cancer	0.000124	0.000212	CcSEcCtD
Trospium—Shock—Doxorubicin—prostate cancer	0.000124	0.000211	CcSEcCtD
Trospium—Nervous system disorder—Doxorubicin—prostate cancer	0.000123	0.000211	CcSEcCtD
Trospium—Rash—Capecitabine—prostate cancer	0.000123	0.00021	CcSEcCtD
Trospium—Pruritus—Prednisone—prostate cancer	0.000123	0.00021	CcSEcCtD
Trospium—Dermatitis—Capecitabine—prostate cancer	0.000123	0.00021	CcSEcCtD
Trospium—Tachycardia—Doxorubicin—prostate cancer	0.000123	0.00021	CcSEcCtD
Trospium—Headache—Capecitabine—prostate cancer	0.000122	0.000209	CcSEcCtD
Trospium—Skin disorder—Doxorubicin—prostate cancer	0.000122	0.000209	CcSEcCtD
Trospium—Hyperhidrosis—Doxorubicin—prostate cancer	0.000122	0.000208	CcSEcCtD
Trospium—Somnolence—Epirubicin—prostate cancer	0.000121	0.000206	CcSEcCtD
Trospium—Nausea—Docetaxel—prostate cancer	0.00012	0.000204	CcSEcCtD
Trospium—Dyspepsia—Epirubicin—prostate cancer	0.00012	0.000204	CcSEcCtD
Trospium—Decreased appetite—Epirubicin—prostate cancer	0.000118	0.000202	CcSEcCtD
Trospium—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000117	0.0002	CcSEcCtD
Trospium—Fatigue—Epirubicin—prostate cancer	0.000117	0.0002	CcSEcCtD
Trospium—Constipation—Epirubicin—prostate cancer	0.000116	0.000198	CcSEcCtD
Trospium—Nausea—Capecitabine—prostate cancer	0.000116	0.000198	CcSEcCtD
Trospium—Dizziness—Prednisone—prostate cancer	0.000115	0.000196	CcSEcCtD
Trospium—Feeling abnormal—Epirubicin—prostate cancer	0.000112	0.000191	CcSEcCtD
Trospium—Somnolence—Doxorubicin—prostate cancer	0.000112	0.000191	CcSEcCtD
Trospium—Gastrointestinal pain—Epirubicin—prostate cancer	0.000111	0.00019	CcSEcCtD
Trospium—Dyspepsia—Doxorubicin—prostate cancer	0.000111	0.000189	CcSEcCtD
Trospium—Vomiting—Prednisone—prostate cancer	0.000111	0.000189	CcSEcCtD
Trospium—Rash—Prednisone—prostate cancer	0.00011	0.000187	CcSEcCtD
Trospium—Dermatitis—Prednisone—prostate cancer	0.00011	0.000187	CcSEcCtD
Trospium—Decreased appetite—Doxorubicin—prostate cancer	0.000109	0.000187	CcSEcCtD
Trospium—Headache—Prednisone—prostate cancer	0.000109	0.000186	CcSEcCtD
Trospium—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000109	0.000185	CcSEcCtD
Trospium—Fatigue—Doxorubicin—prostate cancer	0.000108	0.000185	CcSEcCtD
Trospium—Urticaria—Epirubicin—prostate cancer	0.000108	0.000184	CcSEcCtD
Trospium—Constipation—Doxorubicin—prostate cancer	0.000108	0.000184	CcSEcCtD
Trospium—Abdominal pain—Epirubicin—prostate cancer	0.000107	0.000183	CcSEcCtD
Trospium—Feeling abnormal—Doxorubicin—prostate cancer	0.000104	0.000177	CcSEcCtD
Trospium—Nausea—Prednisone—prostate cancer	0.000103	0.000176	CcSEcCtD
Trospium—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000103	0.000176	CcSEcCtD
Trospium—Urticaria—Doxorubicin—prostate cancer	9.99e-05	0.000171	CcSEcCtD
Trospium—Abdominal pain—Doxorubicin—prostate cancer	9.94e-05	0.00017	CcSEcCtD
Trospium—Asthenia—Epirubicin—prostate cancer	9.75e-05	0.000166	CcSEcCtD
Trospium—Pruritus—Epirubicin—prostate cancer	9.62e-05	0.000164	CcSEcCtD
Trospium—Asthenia—Doxorubicin—prostate cancer	9.03e-05	0.000154	CcSEcCtD
Trospium—Dizziness—Epirubicin—prostate cancer	8.99e-05	0.000153	CcSEcCtD
Trospium—Pruritus—Doxorubicin—prostate cancer	8.9e-05	0.000152	CcSEcCtD
Trospium—Vomiting—Epirubicin—prostate cancer	8.64e-05	0.000148	CcSEcCtD
Trospium—Rash—Epirubicin—prostate cancer	8.57e-05	0.000146	CcSEcCtD
Trospium—Dermatitis—Epirubicin—prostate cancer	8.56e-05	0.000146	CcSEcCtD
Trospium—Headache—Epirubicin—prostate cancer	8.52e-05	0.000145	CcSEcCtD
Trospium—Dizziness—Doxorubicin—prostate cancer	8.32e-05	0.000142	CcSEcCtD
Trospium—Nausea—Epirubicin—prostate cancer	8.08e-05	0.000138	CcSEcCtD
Trospium—Vomiting—Doxorubicin—prostate cancer	8e-05	0.000137	CcSEcCtD
Trospium—Rash—Doxorubicin—prostate cancer	7.93e-05	0.000135	CcSEcCtD
Trospium—Dermatitis—Doxorubicin—prostate cancer	7.92e-05	0.000135	CcSEcCtD
Trospium—Headache—Doxorubicin—prostate cancer	7.88e-05	0.000135	CcSEcCtD
Trospium—Nausea—Doxorubicin—prostate cancer	7.47e-05	0.000128	CcSEcCtD
Trospium—CHRM3—Signaling Pathways—TGFBR2—prostate cancer	2.14e-05	0.00015	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—AKR1C3—prostate cancer	2.13e-05	0.000149	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	2.12e-05	0.000148	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ITPR1—prostate cancer	2.11e-05	0.000148	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PRKACB—prostate cancer	2.11e-05	0.000148	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ITPR1—prostate cancer	2.11e-05	0.000147	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—PIK3CB—prostate cancer	2.09e-05	0.000146	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP17A1—prostate cancer	2.09e-05	0.000146	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—PIK3CB—prostate cancer	2.09e-05	0.000146	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ITPR1—prostate cancer	2.09e-05	0.000146	CbGpPWpGaD
Trospium—CHRM3—Metabolism—MTHFR—prostate cancer	2.08e-05	0.000145	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	2.07e-05	0.000144	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PPARA—prostate cancer	2.04e-05	0.000143	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IGF1R—prostate cancer	2.02e-05	0.000141	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IGF1R—prostate cancer	2.02e-05	0.000141	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CXCL8—prostate cancer	2.01e-05	0.000141	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CXCL8—prostate cancer	2.01e-05	0.00014	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—JAK2—prostate cancer	2e-05	0.00014	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—JAK2—prostate cancer	2e-05	0.00014	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IGF1R—prostate cancer	2e-05	0.000139	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—NCOA2—prostate cancer	1.99e-05	0.000139	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	1.99e-05	0.000139	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—JAK2—prostate cancer	1.98e-05	0.000138	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—LPL—prostate cancer	1.94e-05	0.000135	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—LPL—prostate cancer	1.93e-05	0.000135	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—IL2—prostate cancer	1.92e-05	0.000134	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PDGFRB—prostate cancer	1.92e-05	0.000134	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CAV1—prostate cancer	1.92e-05	0.000134	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—IL2—prostate cancer	1.92e-05	0.000134	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PDGFRB—prostate cancer	1.92e-05	0.000134	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—LPL—prostate cancer	1.91e-05	0.000134	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PIK3CB—prostate cancer	1.9e-05	0.000133	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.9e-05	0.000133	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—IL2—prostate cancer	1.9e-05	0.000133	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	1.9e-05	0.000133	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PIK3CB—prostate cancer	1.9e-05	0.000133	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	1.88e-05	0.000131	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ITGB3—prostate cancer	1.87e-05	0.000131	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ITGB3—prostate cancer	1.87e-05	0.00013	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.86e-05	0.00013	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ITGB3—prostate cancer	1.85e-05	0.000129	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—NQO1—prostate cancer	1.84e-05	0.000128	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CXCL8—prostate cancer	1.83e-05	0.000128	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CXCL8—prostate cancer	1.82e-05	0.000127	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ERBB3—prostate cancer	1.82e-05	0.000127	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FGFR2—prostate cancer	1.81e-05	0.000127	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ERBB3—prostate cancer	1.81e-05	0.000127	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—TH—prostate cancer	1.81e-05	0.000127	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FGFR2—prostate cancer	1.81e-05	0.000126	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	1.8e-05	0.000126	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ERBB3—prostate cancer	1.79e-05	0.000125	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.79e-05	0.000125	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FGFR2—prostate cancer	1.79e-05	0.000125	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.76e-05	0.000123	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CG—prostate cancer	1.75e-05	0.000122	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—IL2—prostate cancer	1.75e-05	0.000122	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—IL2—prostate cancer	1.74e-05	0.000122	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TERT—prostate cancer	1.74e-05	0.000122	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TERT—prostate cancer	1.73e-05	0.000121	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—IL2—prostate cancer	1.72e-05	0.000121	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TERT—prostate cancer	1.72e-05	0.00012	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GGT1—prostate cancer	1.71e-05	0.000119	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—NCOA1—prostate cancer	1.68e-05	0.000117	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HIF1A—prostate cancer	1.66e-05	0.000116	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HIF1A—prostate cancer	1.66e-05	0.000116	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.66e-05	0.000116	CbGpPWpGaD
Trospium—CHRM3—Metabolism—INS—prostate cancer	1.65e-05	0.000116	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HIF1A—prostate cancer	1.64e-05	0.000115	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—LEP—prostate cancer	1.62e-05	0.000114	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CREBBP—prostate cancer	1.62e-05	0.000113	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—LEP—prostate cancer	1.62e-05	0.000113	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CAV1—prostate cancer	1.61e-05	0.000113	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CAV1—prostate cancer	1.6e-05	0.000112	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—LEP—prostate cancer	1.6e-05	0.000112	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—RXRA—prostate cancer	1.6e-05	0.000112	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KDR—prostate cancer	1.59e-05	0.000111	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CAV1—prostate cancer	1.59e-05	0.000111	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KDR—prostate cancer	1.59e-05	0.000111	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KDR—prostate cancer	1.57e-05	0.00011	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ESR1—prostate cancer	1.55e-05	0.000108	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ESR1—prostate cancer	1.55e-05	0.000108	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—COMT—prostate cancer	1.54e-05	0.000108	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CD—prostate cancer	1.54e-05	0.000107	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GSTP1—prostate cancer	1.53e-05	0.000107	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ESR1—prostate cancer	1.53e-05	0.000107	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—BAD—prostate cancer	1.51e-05	0.000106	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—BAD—prostate cancer	1.51e-05	0.000105	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ITPR1—prostate cancer	1.51e-05	0.000105	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—BAD—prostate cancer	1.49e-05	0.000104	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—APC—prostate cancer	1.47e-05	0.000102	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	1.47e-05	0.000102	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—APC—prostate cancer	1.46e-05	0.000102	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	1.46e-05	0.000102	CbGpPWpGaD
Trospium—CHRM3—Metabolism—NOS3—prostate cancer	1.45e-05	0.000101	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EGF—prostate cancer	1.45e-05	0.000101	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IRS1—prostate cancer	1.45e-05	0.000101	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—APC—prostate cancer	1.45e-05	0.000101	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	1.45e-05	0.000101	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IRS1—prostate cancer	1.44e-05	0.000101	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EGF—prostate cancer	1.44e-05	0.000101	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EGF—prostate cancer	1.43e-05	0.0001	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IRS1—prostate cancer	1.43e-05	0.0001	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—TYMS—prostate cancer	1.42e-05	9.95e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GSTM1—prostate cancer	1.41e-05	9.84e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—GSK3B—prostate cancer	1.41e-05	9.83e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—GSK3B—prostate cancer	1.4e-05	9.8e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—GSK3B—prostate cancer	1.39e-05	9.71e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—INS—prostate cancer	1.39e-05	9.7e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—INS—prostate cancer	1.38e-05	9.67e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—LPL—prostate cancer	1.38e-05	9.66e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—INS—prostate cancer	1.37e-05	9.58e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CREBBP—prostate cancer	1.36e-05	9.5e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CREBBP—prostate cancer	1.36e-05	9.47e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IGF1—prostate cancer	1.34e-05	9.38e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CREBBP—prostate cancer	1.34e-05	9.38e-05	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CB—prostate cancer	1.34e-05	9.36e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IGF1—prostate cancer	1.34e-05	9.35e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—EGFR—prostate cancer	1.34e-05	9.34e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.33e-05	9.33e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—EGFR—prostate cancer	1.33e-05	9.31e-05	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PTGS2—prostate cancer	1.33e-05	9.28e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IGF1—prostate cancer	1.33e-05	9.26e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ERCC2—prostate cancer	1.32e-05	9.25e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—EGFR—prostate cancer	1.32e-05	9.22e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	1.3e-05	9.07e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	1.29e-05	9.04e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	1.29e-05	9.01e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	1.29e-05	8.98e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	1.28e-05	8.95e-05	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	1.28e-05	8.92e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	1.28e-05	8.91e-05	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	1.27e-05	8.9e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	1.27e-05	8.89e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	1.27e-05	8.88e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—KRAS—prostate cancer	1.26e-05	8.82e-05	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	1.26e-05	8.81e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	1.26e-05	8.8e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—KRAS—prostate cancer	1.26e-05	8.79e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—KRAS—prostate cancer	1.25e-05	8.71e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—MTHFR—prostate cancer	1.24e-05	8.69e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FGF2—prostate cancer	1.23e-05	8.63e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FGF2—prostate cancer	1.23e-05	8.6e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PPARA—prostate cancer	1.22e-05	8.53e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FGF2—prostate cancer	1.22e-05	8.52e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NOS3—prostate cancer	1.22e-05	8.51e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NOS3—prostate cancer	1.21e-05	8.48e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NOS3—prostate cancer	1.2e-05	8.4e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—JAK2—prostate cancer	1.18e-05	8.27e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—JAK2—prostate cancer	1.18e-05	8.24e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—JAK2—prostate cancer	1.17e-05	8.16e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	1.16e-05	8.1e-05	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PTEN—prostate cancer	1.16e-05	8.09e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	1.16e-05	8.08e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MDM2—prostate cancer	1.15e-05	8.07e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MDM2—prostate cancer	1.15e-05	8.05e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CAV1—prostate cancer	1.15e-05	8.02e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	1.14e-05	8e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MDM2—prostate cancer	1.14e-05	7.97e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ERBB2—prostate cancer	1.14e-05	7.96e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ERBB2—prostate cancer	1.14e-05	7.93e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ERBB2—prostate cancer	1.12e-05	7.85e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	1.12e-05	7.85e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	1.12e-05	7.83e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	1.11e-05	7.75e-05	CbGpPWpGaD
Trospium—CHRM3—Metabolism—EP300—prostate cancer	1.1e-05	7.71e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CXCL8—prostate cancer	1.08e-05	7.55e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CXCL8—prostate cancer	1.08e-05	7.52e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CXCL8—prostate cancer	1.07e-05	7.45e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	1.05e-05	7.37e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	1.05e-05	7.35e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.05e-05	7.3e-05	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	1.04e-05	7.29e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	1.04e-05	7.27e-05	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	1.04e-05	7.27e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CASP3—prostate cancer	1.03e-05	7.22e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IL2—prostate cancer	1.03e-05	7.21e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CASP3—prostate cancer	1.03e-05	7.2e-05	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	1.03e-05	7.2e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IL2—prostate cancer	1.03e-05	7.19e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—IL6—prostate cancer	1.03e-05	7.18e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—IL6—prostate cancer	1.02e-05	7.15e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CASP3—prostate cancer	1.02e-05	7.13e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IL2—prostate cancer	1.02e-05	7.12e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—IL6—prostate cancer	1.01e-05	7.08e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCND1—prostate cancer	1.01e-05	7.03e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCND1—prostate cancer	1e-05	7.01e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	9.96e-06	6.96e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCND1—prostate cancer	9.93e-06	6.94e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	9.93e-06	6.94e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—INS—prostate cancer	9.89e-06	6.91e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	9.83e-06	6.87e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MMP9—prostate cancer	9.77e-06	6.83e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MMP9—prostate cancer	9.74e-06	6.8e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	9.73e-06	6.8e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PTEN—prostate cancer	9.71e-06	6.79e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	9.7e-06	6.78e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CREBBP—prostate cancer	9.69e-06	6.77e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PTEN—prostate cancer	9.68e-06	6.76e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MMP9—prostate cancer	9.64e-06	6.74e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	9.61e-06	6.71e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PTEN—prostate cancer	9.58e-06	6.7e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—AKT1—prostate cancer	9.47e-06	6.62e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—AKT1—prostate cancer	9.44e-06	6.6e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—AKT1—prostate cancer	9.35e-06	6.53e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EP300—prostate cancer	9.26e-06	6.47e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EP300—prostate cancer	9.23e-06	6.45e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CD—prostate cancer	9.19e-06	6.42e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EP300—prostate cancer	9.14e-06	6.39e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—SRC—prostate cancer	9e-06	6.29e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—SRC—prostate cancer	8.98e-06	6.27e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SRC—prostate cancer	8.89e-06	6.21e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—VEGFA—prostate cancer	8.77e-06	6.13e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—VEGFA—prostate cancer	8.74e-06	6.11e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—STAT3—prostate cancer	8.68e-06	6.07e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—NOS3—prostate cancer	8.68e-06	6.06e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—VEGFA—prostate cancer	8.66e-06	6.05e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—STAT3—prostate cancer	8.66e-06	6.05e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—STAT3—prostate cancer	8.57e-06	5.99e-05	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CA—prostate cancer	8.17e-06	5.71e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MYC—prostate cancer	8.07e-06	5.64e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TGFB1—prostate cancer	8.05e-06	5.63e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MYC—prostate cancer	8.04e-06	5.62e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TGFB1—prostate cancer	8.02e-06	5.61e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CB—prostate cancer	8.01e-06	5.6e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MYC—prostate cancer	7.97e-06	5.57e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TGFB1—prostate cancer	7.95e-06	5.55e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PTGS2—prostate cancer	7.94e-06	5.55e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EGFR—prostate cancer	7.89e-06	5.52e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EGFR—prostate cancer	7.87e-06	5.5e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EGFR—prostate cancer	7.79e-06	5.44e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KRAS—prostate cancer	7.46e-06	5.21e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KRAS—prostate cancer	7.43e-06	5.19e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KRAS—prostate cancer	7.36e-06	5.14e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PTEN—prostate cancer	6.92e-06	4.84e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	6.85e-06	4.79e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	6.83e-06	4.77e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	6.76e-06	4.73e-05	CbGpPWpGaD
Trospium—CHRM3—Metabolism—AKT1—prostate cancer	6.67e-06	4.66e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TP53—prostate cancer	6.63e-06	4.63e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TP53—prostate cancer	6.61e-06	4.62e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—EP300—prostate cancer	6.6e-06	4.61e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TP53—prostate cancer	6.54e-06	4.57e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IL6—prostate cancer	6.07e-06	4.24e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IL6—prostate cancer	6.05e-06	4.23e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IL6—prostate cancer	5.99e-06	4.18e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—AKT1—prostate cancer	5.6e-06	3.91e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—AKT1—prostate cancer	5.58e-06	3.9e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—AKT1—prostate cancer	5.52e-06	3.86e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.88e-06	3.41e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—AKT1—prostate cancer	3.99e-06	2.79e-05	CbGpPWpGaD
